Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shih-Pei Wu
Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Nuclear EGFR Contributes to Acquired Resistance to Cetuximab
Oncogene
Cancer Research
Genetics
Molecular Biology
Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance
Clinical Cancer Research
Cancer Research
Oncology
ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Phase 1 Study of EGFR-antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives
Cancer
Cancer Research
Oncology
Cetuximab Promotes Epithelial to Mesenchymal Transition and Cancer Associated Fibroblasts in Patients With Head and Neck Cancer
Oncotarget
Oncology
Platinum-Based Chemotherapy Plus Cetuximab in Head and Neck Cancer
New England Journal of Medicine
Medicine
Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer
Clinical Cancer Research
Cancer Research
Oncology
Cetuximab in Locally Advanced Head-And-Neck Cancer: Defining the Population
Current Oncology
Oncology
Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics